Arch Point Investors Global Blood Therapeutics, Inc. Transaction History

Arch Point Investors

$285 Million
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$32.4 - $68.18 $163,296 - $343,627	-5,040 Reduced 2.9%	168,725 $11.5 Million
Q2 2022 Aug 12, 2022	SELL	$22.3 - $37.39 $89,735 - $150,457	-4,024 Reduced 2.26%	173,765 $5.55 Million
Q1 2022 May 13, 2022	SELL	$25.68 - $35.59 $410,880 - $569,440	-16,000 Reduced 8.26%	177,789 $6.16 Million
Q4 2021 Feb 11, 2022	SELL	$24.9 - $40.26 $74,700 - $120,780	-3,000 Reduced 1.52%	193,789 $5.67 Million
Q3 2021 Nov 12, 2021	BUY	$25.48 - $37.34 $210,999 - $309,212	8,281 Added 4.39%	196,789 $5.01 Million
Q2 2021 Aug 13, 2021	SELL	$32.46 - $43.42 $329,209 - $440,365	-10,142 Reduced 5.11%	188,508 $6.6 Million
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $734,408 - $959,031	-18,860 Reduced 8.67%	198,650 $8.1 Million
Q3 2020 Nov 13, 2020	BUY	$52.76 - $74.49 $1.43 Million - $2.02 Million	27,130 Added 14.25%	217,510 $12 Million
Q2 2020 Jul 31, 2020	BUY	$48.73 - $81.82 $62,082 - $104,238	1,274 Added 0.67%	190,380 $12 Million
Q1 2020 May 13, 2020	BUY	$41.72 - $87.2 $98,042 - $204,920	2,350 Added 1.26%	189,106 $9.66 Million
Q4 2019 Feb 12, 2020	BUY	$45.7 - $81.86 $1.39 Million - $2.5 Million	30,521 Added 19.54%	186,756 $14.8 Million
Q3 2019 Nov 13, 2019	SELL	$45.35 - $57.91 $18,140 - $23,164	-400 Reduced 0.26%	156,235 $7.58 Million
Q2 2019 Jul 26, 2019	BUY	$52.6 - $63.29 $786,370 - $946,185	14,950 Added 10.55%	156,635 $8.24 Million
Q1 2019 May 10, 2019	BUY	$39.99 - $53.48 $79,980 - $106,960	2,000 Added 1.43%	141,685 $7.5 Million
Q4 2018 Feb 14, 2019	BUY	$31.54 - $46.67 $323,285 - $478,367	10,250 Added 7.92%	139,685 $5.73 Million
Q3 2018 Oct 24, 2018	BUY	$38.0 - $51.1 $1.54 Million - $2.07 Million	40,595 Added 45.69%	129,435 $4.92 Million
Q2 2018 Aug 14, 2018	BUY	$38.7 - $50.15 $3.21 Million - $4.15 Million	82,840 Added 1380.67%	88,840 $4.02 Million
Q1 2018 May 15, 2018	BUY	$39.6 - $65.9 $138,600 - $230,650	3,500 Added 140.0%	6,000 $290,000
Q4 2017 Feb 14, 2018	BUY	$29.7 - $45.7 $74,250 - $114,250	2,500	2,500 $98,000

Others Institutions Holding GBT

# of Institutions

Shares Held

288K

Call Options Held

Put Options Held

View Full List

About Global Blood Therapeutics, Inc.

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

More about GBT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arch Point Investors, based on Form 13F filings with the SEC.

News

Stay updated on Arch Point Investors with notifications on news.

Account